Drug abuse remains a critical public health challenge in the US, with more than 80,000 deaths ascribed to opioid overdose, according to the Centers for Disease Control and Prevention (CDC). Thus, the ...
Johnson & Johnson today announced the nipocalimab Biologics License Application (BLA) received Priority Review designation from the U.S Food and Drug Administration (FDA) for the treatment ...